The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP

Journal of Biological Chemistry

Volumn 289, Issue 27, 2014, Pages 19137-19149

  Xie, Rui ^a,b   Xu, Jingyu ^a,b   Wen, Guorong ^a,b   Jin, Hai ^a,b   Liu, Xuemei ^a,b   Yang, Yuan ^a,b   Ji, Bei ^a,b   Jiang, Yixia ^a,b   Song, Penghong ^c   Dong, Hui ^a,b   Tuo, Biguang ^a,b  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b Digestive Disease Institute of Guizhou Province   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGY;

CELLULAR BEHAVIORS; COMPLEX PROCESSES; HEPATOCARCINOGENESIS; HEPATOCELLULAR CARCINOMA; HEPATOCELLULAR CARCINOMA CELL; MOLECULAR PATHWAYS; NUCLEOTIDE RECEPTOR; THERAPEUTIC TARGETS;

CELL SIGNALING;

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE TRIPHOSPHATE; PURINERGIC P2Y2 RECEPTOR; SHORT HAIRPIN RNA; STROMAL INTERACTION MOLECULE 1; SURAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UBIQUITINATION;

ATP; CALCIUM CHANNEL; CALCIUM SIGNALING; CELL PROLIFERATION; HEPATOCELLULAR CARCINOMA; P2Y2 RECEPTOR; PURINERGIC RECEPTOR; STORE-OPERATED CALCIUM CHANNEL; TUMOR MICROENVIRONMENT;

ADENOSINE TRIPHOSPHATE; ADULT; ANIMALS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; RECEPTORS, PURINERGIC P2Y2;

EID: 84903848433     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.540047     Document Type: Article

References (31)

1. Venook, A. P., Papandreou, C., Furuse, J., and de Guevara, L. L. (2010) The incidence and epidemiology of hepatocellular carcinoma: a global andregional perspective. Oncologist 15, 5-13
2. El-Serag, H. B. (2011) Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118-1127
3. Sanyal, A. J., Yoon, S. K., and Lencioni, R. (2010) The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist 15, 14-22
4. Burnstock, G. (2007) Purine and pyrimidine receptors. Cell Mol. Life Sci. 64, 1471-1483
5. Kolachala, V. L., Bajaj, R., Chalasani, M., and Sitaraman, S. V. (2008) Purinergic receptors in gastrointestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G401-G410
6. Nylund, G., Hultman, L., Nordgren, S., and Delbro, D. S. (2007) P2Y2- and P2Y4- purinergic receptors are over-expressed in human colon cancer. Auton. Autacoid Pharmacol. 27, 79-84
7. Künzli, B. M., Berberat, P. O., Giese, T., Csizmadia, E., Kaczmarek, E., Baker, C., Halaceli, I., Büchler, M. W., Friess, H., and Robson, S. C. (2007) Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G223-G230
8. Wagstaff, S. C., Bowler, W. B., Gallagher, J. A., and Hipskind, R. A. (2000) Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c- fos gene expression in MCF-7 breast cancer cells. Carcinogenesis 21, 2175-2181
9. Schafer, R., Sedehizade, F., Welte, T., and Reiser, G. (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285, L376-L385
10. Di Virgilio, F. (2012) Purines, purinergic receptors, and cancer. Cancer Res. 72, 5441-5447
11. von Kügelgen, I., and Harden, T. K. (2011) Molecular pharmacology, physiology, and structure of the P2Y receptors. Adv. Pharmacol. 61, 373-415
12. Roman, R. M., and Fitz, J. G. (1999) Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function. Gastroenterology 116, 964-979
13. Schöfl, C., Ponczek, M., Mader, T., Waring, M., Benecke, H., Von Zur Mühlen, A., Mix, H., Cornberg, M., Böker, K. H. W., Manns, M. P., and Wagner, S. (1999) Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 276, G164-G172
14. Xu, J., Xie, R., Liu, X., Wen, G., Jin, H., Yu, Z., Jiang, Y., Zhao, Z., Yang, Y., Ji, B., Dong, H., and Tuo, B. (2012) Expression and functional role of vacuolar H-ATPase in human hepatocellular carcinoma. Carcinogenesis 33, 2432-2440
15. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) A new generation of Ca2- indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450
16. Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., and Di Virgilio, F. (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 3, e2599
17. Takai, E., Tsukimoto, M., Harada, H., Sawada, K., Moriyama, Y., and Kojima, S. (2012) Autocrine regulation of TGF-1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells. J. Cell Sci. 125, 5051-5060
18. Zhang, Y., Gong, L. H., Zhang, H. Q., Du, Q., You, J. F., Tian, X. X., and Fang, W. G. (2010) Extracellular ATP enhances in vitro invasion of prostate cancer cells by activating Rho GTPase and upregulating MMPs expression. Cancer Lett. 293, 189-197
19. Thevananther, S., Sun, H., Li, D., Arjunan, V., Awad, S. S., Wyllie, S., Zimmerman, T. L., Goss, J. A., and Karpen, S. J. (2004) Extracellular ATP activates C-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 39, 393-402
20. Sun, X., Han, L., Seth, P., Bian, S., Li, L., Csizmadia, E., Junger, W. G., Schmelzle, M., Usheva, A., Tapper, E. B., Baffy, G., Sukhatme, V. P., Wu, Y., and Robson, S. C. (2013) Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/Entpd1 null mice. Hepatology 57, 205-216
21. Geschwind, J. F., Ko, Y. H., Torbenson, M. S., Magee, C., Pedersen, P. L. (2002) Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 62, 3909-3913
22. Lu, H., Ouyang, W., and Huang, C. (2006) Inflammation, a key event in cancer development. Mol. Cancer Res. 4, 221-233
23. Birrer, R. B., Birrer, D., and Klavins, J. V. (2003) Hepatocellular carcinoma and hepatitis virus. Ann. Clin. Lab. Sci. 33, 39-54
24. Chiba, T., Marusawa, H., and Ushijima, T. (2012) Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 143, 550-563
25. Colotta, F., Allavena, P., Sica, A., Garlanda, C., and Mantovani, A. (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081
26. Monteith, G. R., McAndrew, D., Faddy, H. M., and Roberts-Thomson, S. J. (2007) Calcium and cancer: targeting Ca2- transport. Nat. Rev. Cancer 7, 519-530
27. Lewis, R. S. (2011) Store-operated calcium channels: new perspectives on mechanism and function. Cold Spring Harb. Perspect. Biol. 3, a003970
28. Madsen, C. P., Klausen, T. K., Fabian, A., Hansen, B. J., Pedersen, S. F., and Hoffmann, E. K. (2012)Onthe role of TRPC1 in control of Ca2- influx, cell volume, and cell cycle. Am. J. Physiol. Cell Physiol. 303, C625-C634
29. Molnar, T., Barabas, P., Birnbaumer, L., Punzo, C., Kefalov, V., and Križaj, D. (2012) Store-operated channels regulate intracellular calcium in mammalian rods. J. Physiol. 590, 3465-3481
30. Mínguez, B., Tovar, V., Chiang, D., Villanueva, A., and Llovet, J. M. (2009) Pathogenesis of hepatocellular carcinoma and molecular therapies. Curr. Opin. Gastroenterol. 25, 186-194
31. Mbeunkui, F., and Johann, D. J., Jr. (2009) Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother. Pharmacol. 63, 571-582